Moreover, the decreased binding of AD GAGs to FGF-1 is in accord with previous works in where FGF-1 acted as a neuropoietic mediator and promoter of neuron survival in brain [38, 39]. This evidence concerns the gene FGF1 and Alzheimer disease.